The Impact of Primary Tumor Volume on Survival of Patients with Non-Surgically Treated Advanced-Stage Hypopharyngeal Cancer- Retrospective Study and Literature Overview

被引:0
|
作者
Jakovljevic, Sasa [1 ,2 ]
Djordjevic, Vladimir [1 ,2 ]
Tomanovic, Nada [1 ,3 ]
Arsovic, Nenad [1 ,2 ]
Dudvarski, Zoran [1 ,2 ]
Ursulovic, Tamara [4 ]
Laketic, Darko [1 ,5 ]
Jovanovic, Katarina [2 ]
Arsovic, Konstantin [2 ]
Radivojevic, Nemanja [1 ,2 ]
机构
[1] Univ Belgrade, Fac Med, Belgrade 11000, Serbia
[2] Univ Clin Ctr Serbia, Clin Otorhinolaryngol & Maxillofacial Surg, Belgrade, Serbia
[3] Inst Pathol, Belgrade, Serbia
[4] Inst Oncol & Radiol Serbia, Belgrade, Serbia
[5] Inst Anat, Belgrade, Serbia
关键词
Advanced hypopharyngeal cancer; Cancer prognosis; Non-surgical treatment; Tumor volume; Survival; SQUAMOUS-CELL CARCINOMA; ADVANCED HEAD; NECK-CANCER; LARYNX CANCER; PROGNOSTIC-FACTORS; LOCAL-CONTROL; RADIOCHEMOTHERAPY; CHEMORADIATION; PRESERVATION; RADIOTHERAPY;
D O I
10.1007/s12070-024-05139-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
To determine the prognostic value of tumor volume in predicting the survival in patients with stage III-IV of hypopharyngeal carcinoma. We studied 71 patients with advanced stage of hypopharyngeal carcinoma. The volume of primary tumor was calculated by approximation of the ellipsoid volume. Correlation between carcinoma volume and demographic, clinical and carcinoma characteristics has shown that male patients and patients consuming alcohol had greater tumor volumes. The median of overall survival was at 12 months (95% CI: 9.25-14.75); the median of progression-free survival was at 9 months (95% CI: 6.6-11.3). ROC Curve Analysis of carcinoma volumes in outcome prediction shows that the cutoff of 14.69 had the sensitivity of 61% and specifics of 89%. Based on significant independent impact of tumor volume on survival, it is important to include this parameter among possible new treatment protocols.
引用
收藏
页码:184 / 193
页数:10
相关论文
共 22 条
  • [1] PROGNOSTIC IMPACT OF TUMOR VOLUME IN PATIENTS WITH STAGE III-IVA HYPOPHARYNGEAL CANCER WITHOUT BULKY LYMPH NODES TREATED WITH DEFINITIVE CONCURRENT CHEMORADIOTHERAPY
    Chen, Shang-Wen
    Yang, Shih-Neng
    Liang, Ji-An
    Lin, Fang-Jen
    Tsai, Ming-Hsui
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (06): : 709 - 716
  • [2] Impact of postoperative complications after primary tumor resection on survival in patients with incurable stage IV colorectal cancer: A multicenter retrospective cohort study
    Fujita, Yusuke
    Hida, Koya
    Hoshino, Nobuaki
    Sakai, Yoshiharu
    Konishi, Tsuyoshi
    Kanazawa, Akiyoshi
    Goto, Michitoshi
    Saito, Shuji
    Suda, Tadashi
    Watanabe, Masahiko
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (03): : 354 - 362
  • [3] Differential impact of post-neoadjuvant stage on overall survival for surgically treated oesophageal cancer following neoadjuvant chemotherapy or chemoradiation: a retrospective cohort study
    Gunadasa, Indika
    Papa, Nathan
    Khu, Yin Li
    Brown, Wendy
    Burton, Paul
    Haydon, Andrew
    Zalcberg, John
    ANNALS OF ESOPHAGUS, 2024, 7
  • [4] Prognostic factors for survival in Stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume
    Basaki, K
    Abe, Y
    Aoki, M
    Kondo, H
    Hatayama, Y
    Nakaji, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02): : 449 - 454
  • [5] Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study
    Kawamura, Hidetaka
    Ogawa, Yusuke
    Yamazaki, Hajime
    Honda, Michitaka
    Kono, Koji
    Konno, Shinichi
    Fukuhara, Shunichi
    Yamamoto, Yosuke
    WORLD JOURNAL OF SURGERY, 2021, 45 (10) : 3230 - 3239
  • [6] Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy A Study of the Canadian Head & Neck Collaborative Research Initiative
    Malik, Nauman H.
    Fu, Rui
    Hainc, Nicolin
    Noel, Christopher W.
    de Almeida, John R.
    Hosni, Ali
    Huang, Shao Hui
    Yu, Eugene
    Dzioba, Agnieszka
    Leung, Andrew
    Mangat, Arvindpaul
    MacNeil, Danielle
    Nichols, Anthony C.
    Hiremath, Shivaprakash B.
    Chakraborty, Santanu
    Jooya, Alboorz
    Gaudet, Marc
    Johnson-Obaseki, Stephanie
    Whelan, Jonathan
    Forghani, Reza
    Hier, Michael P.
    Morand, Gregoire
    Sultanem, Khalil
    Dort, Joseph
    Lysack, John
    Matthews, Wayne
    Nakoneshny, Steven
    Gill, Gia
    Globerman, Adam
    Kerr, Paul
    Maralani, Pejman
    Karam, Irene
    Eskander, Antoine
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (02) : 103 - 109
  • [7] Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
    Takahashi, Noriyoshi
    Yamamoto, Takaya
    Matsushita, Haruo
    Sugawara, Toshiyuki
    Kubozono, Masaki
    Umezawa, Rei
    Ishikawa, Yojiro
    Kozumi, Maiko
    Katagiri, Yu
    Tasaka, Syun
    Takeda, Kazuya
    Takeda, Ken
    Dobashi, Suguru
    Jingu, Keiichi
    JOURNAL OF RADIATION RESEARCH, 2016, 57 (06) : 655 - 661
  • [8] Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study
    Xuefeng Yu
    Fulan Hu
    Qiang Yao
    Chunfeng Li
    Hongfeng Zhang
    Yingwei Xue
    BMC Cancer, 16
  • [9] Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study
    Yu, Xuefeng
    Hu, Fulan
    Yao, Qiang
    Li, Chunfeng
    Zhang, Hongfeng
    Xue, Yingwei
    BMC CANCER, 2016, 16
  • [10] Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy
    Stinchcombe, TE
    Morris, DE
    Moore, DT
    Bechtel, JH
    Halle, JS
    Mears, A
    Deschesne, K
    Rosenman, JG
    Socinski, MA
    LUNG CANCER, 2006, 52 (01) : 67 - 74